As Vice President of Cancer Biomarker Development at AstraZeneca, Jorge Reis-Filho seeks to develop and validate the next generation of mechanistically informed and clinically deployable biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results